Consistent with the CGGA and TCGA analyses, the immunohistochemistry assay also revealed that a high level of MELK was associated with older age, increased WHO grade, IDH wild type, and 1p19q non-codeletion molecular subtypes, all of which represent higher malignancy of glioma. This evidence concerns the gene MELK and glioma.